Terns Pharmaceuticals, Inc. (TERN) Social Stream



Terns Pharmaceuticals, Inc. (TERN): $6.53

0.37 (+6.01%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

TERNS PHARMACEUTICALS INC (TERN) Price Targets From Analysts

Use the tables below to see what analysts covering TERNS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-22 1 $19 $19 $19 $5.86 224.23%
2022-03-07 2 $19 $19 $19 $5.86 224.23%
2022-05-18 2 $6 $6 $6 $5.86 2.39%
2022-08-10 2 $5 $5 $5 $5.86 -14.68%
2022-09-12 3 $6 $5 $5.5 $5.86 -6.14%
2022-11-11 4 $9 $5 $6.666 $5.86 13.75%
2022-11-21 4 $9 $6 $7 $5.86 19.45%
2022-12-20 4 $14 $6 $8.666 $5.86 47.88%
2022-12-29 4 $14 $6 $9 $5.86 53.58%
2023-02-07 5 $19 $6 $11.5 $5.86 96.25%
2023-03-29 6 $19 $9 $14 $5.86 138.91%
2023-05-19 6 $19 $10 $14.2 $5.86 142.32%
2023-05-31 8 $23 $10 $15.666 $5.86 167.34%
2023-06-07 8 $23 $10 $16 $5.86 173.04%
2023-06-22 9 $23 $10 $16 $5.86 173.04%
2023-08-08 10 $23 $10 $16.222 $5.86 176.83%
2023-08-09 10 $25 $8 $16.333 $5.86 178.72%
2023-11-16 9 $19 $8 $15.125 $5.86 158.11%
2023-11-27 9 $19 $8 $14.25 $5.86 143.17%

The Trend in the Analyst Price Target


TERN's average price target has moved up $8.25 over the prior 20 months.

Over the past 42 weeks, TERN's average upside potential has been 87.48%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-29 6 19 9 14.000 12.00 16.67%
2023-06-22 9 23 10 16.222 11.85 36.89%
2023-08-08 10 23 10 16.222 6.99 132.07%
2023-11-16 9 19 8 15.125 3.65 314.38%
2023-11-27 9 19 8 14.250 3.86 269.17%

TERN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


Over the past 52 weeks, TERN's average broker recommendation rating improved by 0.56.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TERN as an investment opportunity.

  • TERNS PHARMACEUTICALS INC's average analyst price target is higher than 385.73% of all US stocks.
  • TERN has a lower variance in analysts' estimates than -1622.64% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, TERNS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1891.61% of them.
  • TERNS PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1602.95% of stocks in the small market cap category.

Stocks similar to TERNS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SNSE, PHVS, and ADAG.

Is TERN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!